Association between Lower Extremity Skeletal Muscle Mass and Impaired Cognitive Function in Type 2 Diabetes

[1]  Ashleigh E. Smith,et al.  Cross-sectional associations between metabolic syndrome and performance across cognitive domains: A systematic review , 2019, Applied neuropsychology. Adult.

[2]  K. Neelam,et al.  Excess visceral adiposity is associated with diabetic retinopathy in a multiethnic Asian cohort with longstanding type 2 diabetes , 2018, Endocrine research.

[3]  R. Yu,et al.  The Effects of Combinations of Cognitive Impairment and Pre-frailty on Adverse Outcomes from a Prospective Community-Based Cohort Study of Older Chinese People , 2018, Front. Med..

[4]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[5]  Tao Chen,et al.  Physical Frailty is Associated with Longitudinal Decline in Global Cognitive Function in Non-Demented Older Adults: A Prospective Study , 2018, The journal of nutrition, health & aging.

[6]  R. Holtzer,et al.  Differential associations of functional and cognitive health outcomes with pre-frailty and frailty states in community-dwelling older adults , 2020, Journal of health psychology.

[7]  J. Losa-Reyna,et al.  Cognitive Performance across 3 Frailty Phenotypes: Toledo Study for Healthy Aging. , 2017, Journal of the American Medical Directors Association.

[8]  H. Hamasaki Lower Extremity Skeletal Muscle Mass, but Not Upper Extremity Skeletal Muscle Mass, Is Inversely Associated with Hospitalization in Patients with Type 2 Diabetes , 2017, Journal of diabetes research.

[9]  B. Giacobbo,et al.  Multimodal physical activity increases brain-derived neurotrophic factor levels and improves cognition in institutionalized older women , 2017, GeroScience.

[10]  B. Giacobbo,et al.  Multimodal physical activity increases brain-derived neurotrophic factor levels and improves cognition in institutionalized older women , 2017, GeroScience.

[11]  C. Cooper,et al.  Epidemiology of sarcopenia and insight into possible therapeutic targets , 2017, Nature Reviews Rheumatology.

[12]  D. Kapogiannis,et al.  Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease , 2017, Front. Aging Neurosci..

[13]  E. Freiberger,et al.  Prevalence of sarcopenia and sarcopenic obesity in older German men using recognized definitions: high accordance but low overlap! , 2017, Osteoporosis International.

[14]  Tih-Shih Lee,et al.  Physical Frailty, Cognitive Impairment, and the Risk of Neurocognitive Disorder in the Singapore Longitudinal Ageing Studies , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  Der-Sheng Han,et al.  Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis. , 2016, Journal of the American Medical Directors Association.

[16]  S. Volpato,et al.  Muscle dysfunction in type 2 diabetes: a major threat to patient’s mobility and independence , 2016, Acta Diabetologica.

[17]  A. Arora,et al.  HANDGRIP STRENGTH IN PATIENTS WITH TYPE 2 DIABETES MELLITUS , 2016 .

[18]  H. Jang Sarcopenia, Frailty, and Diabetes in Older Adults , 2016, Diabetes & metabolism journal.

[19]  M. Yamada,et al.  Sarcopenia as a Risk Factor for Cognitive Deterioration in Community-Dwelling Older Adults: A 1-Year Prospective Study. , 2016, Journal of the American Medical Directors Association.

[20]  G. Shefer,et al.  Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age — An overview , 2016, Experimental Gerontology.

[21]  ChenLiang-Yu,et al.  Association of Dynapenia, Sarcopenia, and Cognitive Impairment Among Community-Dwelling Older Taiwanese. , 2016 .

[22]  M. Zunzunegui,et al.  Sarcopenic obesity and physical performance in middle aged women: a cross-sectional study in Northeast Brazil , 2015, BMC Public Health.

[23]  Erick O. Hernández-Ochoa,et al.  Diabetic Myopathy and Mechanisms of Disease , 2015, Biochemistry & pharmacology : open access.

[24]  H. Katsuyama,et al.  Associations between lower extremity muscle mass and metabolic parameters related to obesity in Japanese obese patients with type 2 diabetes , 2015, PeerJ.

[25]  Y. Cheung,et al.  The Equivalence and Difference between the English and Chinese Language Versions of the Repeatable Battery for the Assessment of Neuropsychological Status , 2015, The Clinical neuropsychologist.

[26]  J. Galvin,et al.  Sarcopenia and impairment in cognitive and physical performance , 2015, Clinical interventions in aging.

[27]  S. Lim,et al.  Evaluation of body adiposity index as a predictor of aortic stiffness in multi-ethnic Asian population with type 2 diabetes , 2015, Diabetes & vascular disease research.

[28]  J. Boudet,et al.  Update on cognitive decline and dementia in elderly patients with diabetes. , 2014, Diabetes & metabolism.

[29]  R. Kenny,et al.  Cognitive Function in the Prefrailty and Frailty Syndrome , 2014, Journal of the American Geriatrics Society.

[30]  T. Ng,et al.  Normative data for the repeatable battery for the assessment of neuropsychological status in elderly Chinese. , 2014, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[31]  L. Peng,et al.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. , 2014, Journal of the American Medical Directors Association.

[32]  Liang‐Kung Chen,et al.  Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: A cross‐sectional study , 2014, Geriatrics & gerontology international.

[33]  G. Savva,et al.  Frailty and cognitive impairment—A review of the evidence and causal mechanisms , 2013, Ageing Research Reviews.

[34]  M. Cesari,et al.  Association of a 7-year percent change in fat mass and muscle mass with subsequent cognitive dysfunction: the EPIDOS-Toulouse cohort , 2013, Journal of cachexia, sarcopenia and muscle.

[35]  D. Munguía-Izquierdo,et al.  Objectively measured sedentary time and physical activity in women with fibromyalgia: a cross-sectional study , 2013, BMJ Open.

[36]  C. Annweiler,et al.  Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. , 2013, Age and ageing.

[37]  M. Levine,et al.  Sarcopenic Obesity and Cognitive Functioning: The Mediating Roles of Insulin Resistance and Inflammation? , 2012, Current gerontology and geriatrics research.

[38]  C. Annweiler,et al.  Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[39]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[40]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[41]  B. Heitmann,et al.  Thigh circumference and risk of heart disease and premature death: prospective cohort study , 2009, BMJ : British Medical Journal.

[42]  Suzanne Satterfield,et al.  Do Muscle Mass, Muscle Density, Strength, and Physical Function Similarly Influence Risk of Hospitalization in Older Adults? , 2009, Journal of the American Geriatrics Society.

[43]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[44]  T. Ng,et al.  Criterion-based validity and reliability of the Geriatric Depression Screening Scale (GDS-15) in a large validation sample of community-living Asian older adults , 2009, Aging & mental health.

[45]  S. Bandinelli,et al.  Skeletal muscle and mortality results from the InCHIANTI Study. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[46]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[47]  J. Manson,et al.  Prospective Study of , 2007 .

[48]  W. Mitch,et al.  Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. , 2006, Endocrinology.

[49]  Mehmet Akif Buyukbese,et al.  Hand grip strength in patients with type 2 diabetes mellitus. , 2005, Diabetes research and clinical practice.

[50]  J. Williamson,et al.  Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies , 2005, Diabetologia.

[51]  D. Selkoe,et al.  Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. , 2004, The American journal of pathology.

[52]  R. Ross,et al.  Estimation of skeletal muscle mass by bioelectrical impedance analysis. , 2000, Journal of applied physiology.

[53]  C. Randolph,et al.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. , 1998, Journal of clinical and experimental neuropsychology.

[54]  S. Heymsfield,et al.  Epidemiology of sarcopenia among the elderly in New Mexico. , 1998, American journal of epidemiology.